These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2484088)

  • 1. Comparisons of the electrophysiological effects of intravenous sotalol and propranolol on the immature mammalian heart.
    Xu H; Villafane J; McCormack J; Stolfi A; Gelband H; Pickoff AS
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):925-9. PubMed ID: 2484088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects of sotalol on the immature mammalian heart.
    Houyel L; Fournier A; Ducharme G; Chartrand C; Davignon A
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):134-9. PubMed ID: 1375680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
    Gomoll AW; Bartek MJ
    Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic effects of intravenous propranolol in the intact immature mammalian heart.
    Young ML; Fournier A; Stolfi A; Pickoff AS
    Dev Pharmacol Ther; 1988; 11(3):125-34. PubMed ID: 3383724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
    Nakaya H; Kimura S; Nakao Y; Kanno M
    Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the beta-adrenergic blocking agents propranolol and timolol on canine cardiac refractory periods.
    Jaillon P; Weissenburger J; Heckle J; Cheymol G
    Eur J Pharmacol; 1979 Oct; 58(3):265-71. PubMed ID: 510358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-catecholamine-mediated electrophysiological effects of intravenous bethanidine sulfate on the immature mammalian heart.
    Villafane J; Xu H; McCormack J; Gelband H; Stolfi A; Pickoff AS
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):486-91. PubMed ID: 2465451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs.
    Wallace AA; Stupienski RF; Brookes LM; Selnick HG; Claremon DA; Lynch JJ
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):687-95. PubMed ID: 1723765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol.
    Spinelli W; Parsons RW; Colatsky TJ
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):913-22. PubMed ID: 1282594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sotalol controlled-release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects.
    Labhasetwar V; Underwood T; Gallagher M; Murphy G; Langberg J; Levy RJ
    J Pharm Sci; 1994 Feb; 83(2):156-64. PubMed ID: 8169781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use-dependent electrophysiologic effects of DL-sotalol and modulation by isoproterenol in the human ventricle.
    Naitoh N; Furushima H; Ohira K; Taneda K; Aizawa Y
    Jpn Heart J; 1998 Mar; 39(2):153-61. PubMed ID: 9687824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute cardiac electrophysiological effects of intravenous sotalol hydrochloride.
    Ward DE; Camm AJ; Spurrell RA
    Clin Cardiol; 1979 Jun; 2(3):185-91. PubMed ID: 509798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C; Drolet B; Hamelin BA; Turgeon J
    J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].
    Kaverina NV; Lyskovtsev VV; Popova EP
    Eksp Klin Farmakol; 2003; 66(1):27-33. PubMed ID: 12683077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol.
    Antonaccio MJ; Gomoll A
    Am J Cardiol; 1993 Aug; 72(4):27A-37A. PubMed ID: 8346723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental effects of d-sotalol on anterograde and retrograde atrioventricular conduction in the rabbit.
    Case CL; Le FK; McKay CA; Gillette PC; Hewett KW
    J Cardiovasc Electrophysiol; 1996 May; 7(5):406-14. PubMed ID: 8722586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of procainamide and dl-sotalol on the changes of atrial electrophysiology induced by high current stimulation.
    Yu WC; Chen SA; Tai CT; Wen ZC; Feng AN; Ding YA; Chang MS
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2064-9. PubMed ID: 9826857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
    Kaplan HR; Commarato MA
    J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.